Production methods for nanodrug particles using the bottom-up approach

https://doi.org/10.1016/j.addr.2011.03.011Get rights and content

Abstract

This review focuses on bottom-up processes such as precipitation (or crystallisation) and single droplet evaporation to produce nanoparticles containing largely pure therapeutics for pharmaceutical applications. Suitable precipitation techniques involve the use of high-gravity, confined impinging liquid jet mixing, multi-inlet vortex mixing, supercritical fluids, and ultrasonic waves. Droplet evaporation methods are spray-based, including nanospray drying, aerosol flow reactor method, spraying of low-boiling point solvent under ambient conditions and electrospraying of low-electrical conducting solutions. A key to the success of yielding stable nanoparticles in these various techniques is to control the particle growth kinetics through evaporation rate of the droplets or mixing rate during precipitation.

Introduction

One of the major attractions of using pure drug nanoparticles is their chemical simplicity without the presence of many additives or excipients. New drug compounds have low aqueous solubility, which poses formulation and delivery challenges. Formulating these drugs as organic solutions or oil-in-water emulsions is not always practical due to the toxicity of organic solvents and limitations in the liquid volume conducive for convenient dose administration, storage, and handling. Nanoparticles have very high specific surface areas (i.e. surface area-to-mass ratios) thus can be an alternative for enhancing the dissolution rate of poorly soluble drugs. Regardless of the production method, stability is an important formulation requirement for nanoparticles. Ideally the nanoparticles should be crystalline because amorphous materials are generally unstable, cohesive, potentially hygroscopic, and prone to recrystallisation. The instability will adversely affect the pharmaceutical product as a whole. However, it may be acceptable if the amorphous compound can remain stable for a sufficiently long period of time during processing and storage.

Nanoparticle production methods can be classified into the top-down and bottom-up categories. Top-down approaches involve the size-reduction of large particles to the nanometre range. This can be achieved by milling or high pressure homogenisation and has been discussed in the excellent reviews by Müller [1], [2], [3], [4], [5], [6]. Briefly, in milling the drug particles are broken down by impaction by milling balls. To minimise the amorphous content, the drug particles can be milled whilst suspended in a suitable non-solvent, usually water for hydrophobic drugs. This encourages recrystallisation of any amorphous regions formed during milling. For example, a danazol nanosuspension was produced by milling the drug particles in water containing polyvinylpyrrolidone K-15 [7]. The weight average diameter of the resultant crystalline danazol particles was 222.2 nm [7]. The two major types of high pressure homogenisation are microfluidisation and piston-gap homogenisation. Microfluidisation is essentially air-jet milling, in which the particles are fragmented by collision in a high pressure air jet. On the other hand, piston-gap homogenisation involves forcing a liquid suspension at high pressure through a narrow channel or gap inside a pipe. For aqueous media, bubbles form inside the gap due to a reduction in the static pressure of the liquid in this region [8]. These bubbles collapse upon exiting the narrow gap and the cavitation energy generated consequently breaks up the particles. For non-aqueous media or oil, the particles are comminuted by the collision and high shear though the gap.

In contrast to top-down techniques, bottom-up methods generate nanoparticles by building them from drug molecules in solution. This can be achieved by controlled precipitation (or crystallisation) and evaporation. These processes can occur in the bulk solution or in droplets, depending on the technique. There are pros and cons to both top-down and bottom-up methods. Generally, top-down techniques produce nanoparticles that are mostly crystalline but high energy or pressure is required to achieve nano-range comminution, which may also lead to contamination if a milling medium is used. In contrast, bottom-up processes involve dissolution, followed by precipitation or drying. The mechanical energy input is thus minimal but the resultant nanoparticles can be crystalline or amorphous, depending on the process conditions. Even if the particles are crystalline, the crystal growth rate must be controlled to limit the particle size. Details on these issues and the principles of various bottom-up methods will be discussed in this review.

Section snippets

Basic principles

Precipitation consists of several main steps: chemical reaction (and the subsequent supersaturation), nucleation, solute diffusion and particle growth [9]. Nucleation rate (dN/dt) can be expressed asdNdt=KnCiCawhere Kn is the solute nucleation constant, Ci and C are the solute concentration on the particle surface and saturation concentration, respectively. The value of the parameter a is usually between 5 and 18.

The diffusion rate of solute to the particle surface isdmdt=KdCCiwhere Kd is

Basic principles

When a drug solution of concentration C is atomised into droplets of diameter D, the diameter d of the drug particles with density ρ after evaporation of the solvent is given byd=D[C/ρ]1/3.

The particle density may not reach the true density of the drug and will depend on how the drug precipitating out from the droplet arranges to form the resulting particle.

Spray drying

In spray drying, a drug solution (aqueous or organic) is atomised to fine droplets which are evaporated in a warm air current to form dry

Conclusions

The major aspects of nanoparticle production by bottom-up processes involving solvent precipitation and droplet evaporation have been reviewed in this article. This is an area of growing interest as the number of marketed products employing nanotechnology is expected to increase. Although specific production techniques vary, they converge at the point of controlling the particle growth kinetics through mixing rate during precipitation or evaporation rate of the droplets. The relevant aspects of

References (77)

  • Y. Liu et al.

    Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation

    Chemical Engineering Science.

    (2008)
  • K. Byrappa et al.

    Nanoparticles synthesis using supercritical fluid technology — towards biomedical applications

    Advanced Drug Delivery Reviews

    (2008)
  • E. Reverchon et al.

    Nanoparticles production by supercritical antisolvent precipitation: a general interpretation

    Journal of Supercritical Fluids.

    (2007)
  • M.D. Luque de Castro et al.

    Ultrasound-assisted crystallization (sonocrystallization)

    Ultrasonics Sonochemistry

    (2007)
  • A. Abbas et al.

    Sonocrystallisation of sodium chloride particles for inhalation

    Chemical Engineering Science.

    (2007)
  • R.S. Dhumal et al.

    Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery

    International Journal of Pharmaceutics

    (2009)
  • R.S. Dhumal et al.

    Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability

    European Journal of Pharmaceutics and Biopharmaceutics

    (2008)
  • M.T. Vidgren et al.

    Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate

    International Journal of Pharmaceutics

    (1987)
  • A. Chawla et al.

    Production of spray dried salbutamol sulfate for use in dry powder aerosol formulation

    International Journal of Pharmaceutics

    (1994)
  • S.H. Lee et al.

    Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy

    International Journal of Pharmaceutics

    (2011)
  • H. Eerikäinen et al.

    Aerosol flow reactor method for synthesis of drug nanoparticles

    European Journal of Pharmaceutics and Biopharmaceutics

    (2003)
  • H.-K. Chan et al.

    Respirable form of crystals of cromoglycic acid

    Journal of Pharmaceutical Sciences

    (1989)
  • H.-K. Chan et al.

    Aerodynamic properties of elongated particles of cromoglycic acid

    Journal of Aerosol Science.

    (1989)
  • A. Jaworek

    Micro- and nanoparticle production by electrospraying

    Powder Technology.

    (2007)
  • A. Gomez et al.

    Production of protein nanoparticles by electrospray drying

    Journal of Aerosol Science.

    (1998)
  • D.-R. Chen et al.

    Electrospraying of conducting liquids for monodisperse aerosol generation in the 4 nm to 1.8 μm diameter range

    Journal of Aerosol Science.

    (1995)
  • J. Zhong et al.

    Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment

    International Journal of Pharmaceutics

    (2005)
  • H. Chiou et al.

    Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation

    International Journal of Pharmaceutics

    (2007)
  • T. Hu et al.

    Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation

    Journal of Pharmaceutical Sciences

    (2008)
  • S.-D. Yeo et al.

    Formation of polymer particles with supercritical fluids: a review

    Journal of Supercritical Fluids.

    (2005)
  • C. Keck et al.

    Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystals technology

    Dosis.

    (2008)
  • G.G. Liversidge et al.

    Surface modified drug nanoparticles

    (1992)
  • R.H. Muller et al.

    Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution

    (1999)
  • R.C. Oppenheim et al.

    Injectable compositions, nanoparticles useful therein, and process of manufacturing same

    (1978)
  • M. List et al.

    Pharmaceutical colloidal hydrosols for injection

    (1988)
  • P. Gassmann et al.

    Improvements in pharmaceutical compositions

    (1992)
  • M. List et al.

    Hydrosols of pharmacologically active agents and their pharmaceutical compositions comprising them

    (1995)
  • P. Gassmann et al.

    Pharmaceutical compositions comprised of stabilized peptide particles

    (2002)
  • Cited by (370)

    View all citing articles on Scopus

    This review is part of the Advanced Drug Delivery Reviews theme issue on "Nanodrug Particles and Nanoformulations for Drug Delivery".

    View full text